SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-21-000128
Filing Date
2021-01-19
Accepted
2021-01-19 10:57:38
Documents
5
Period of Report
2021-01-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K embi_8k.htm 8-K 19329
2 EX-3.1 embi_ex31.htm EX-3.1 875
3 EX-99.1 embi_ex991.htm EX-99.1 1758
4 embi_ex991img1.jpg GRAPHIC 241960
5 embi_ex991img2.jpg GRAPHIC 65341
  Complete submission text file 0001640334-21-000128.txt   446850
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 21534531
SIC: 2834 Pharmaceutical Preparations